A Dallas mom fought back from her own life-threatening illness, and she's now using her experience to address a significant need in the healthcare system.
The founder of an Arizona pharmaceutical company was ordered to spend 5 1/2 years in prison Thursday for orchestrating a bribery and kickback scheme prosecutors said helped fuel the opioid crisis.
The U.S. Food and Drug Administration approved an ovarian cancer drug for the maintenance and treatment of pancreatic cancer, according to AstraZeneca and Merck.
Some deadly diseases that seemed headed for eradication in recent decades have been making a scary comeback in the past 10 years.
Ubrogepant, a new class of drug to treat acute migraine attacks, shows promise to treat patients who have previously lacked other options.
Open Enrollment has begun. Over the next month, millions of Americans will choose their health insurance coverage for 2020. A human resources consultant says it's important to get started, compare your options, and pick the right plan for you.